EPO (Erythropoietin)

EPO (Erythropoietin) — Research-Grade Glycoprotein | 3,000 IU/vial

Erythropoietin (EPO) is one of the most extensively researched glycoprotein hormones in hematology, endurance physiology, and regenerative medicine. Naturally produced by the kidneys in response to low oxygen tension, EPO acts on erythroid progenitor cells in the bone marrow to stimulate the production of red blood cells (erythrocytes). EhBuddy Peptides offers research-grade EPO at 3,000 IU per lyophilized vial, manufactured for precision in vitro and in vivo research applications.

Available Format

• 3,000 IU/vial — Lyophilized powder, suitable for reconstitution and research use

Reconstitution

EPO lyophilized powder requires liquid reconstitution prior to use in research protocols. Recommended reconstitution agents:

• Bacteriostatic Water (BAC Water) — Preferred for extended stability and multi-use vials in research settings
• Sterile Water — Suitable for single-use reconstitution protocols

Store lyophilized vials at 2–8°C. Once reconstituted, store at 2–8°C and use within research protocol timeframes.

Key Areas of Research Interest

🔴 Erythropoiesis Stimulation & Oxygen Transport

EPO’s primary and best-documented mechanism involves binding to EPO receptors on erythroid progenitor cells, triggering a signaling cascade that accelerates red blood cell differentiation and production. Research models consistently demonstrate measurable increases in hematocrit, hemoglobin concentration, and circulating erythrocyte volume following EPO administration — translating directly to enhanced oxygen-carrying capacity in experimental subjects.

⚡ Endurance & Aerobic Capacity Research

EPO is among the most studied compounds in exercise physiology and endurance research. Studies in animal models have demonstrated significant improvements in VO₂ max, time-to-exhaustion, and aerobic work capacity following EPO treatment. Researchers investigating the physiological limits of oxygen utilization, altitude adaptation, and cardiovascular performance consistently turn to EPO as a reference compound.

🧠 Neuroprotection & Brain Research

Beyond hematology, EPO has drawn significant attention from neuroscience researchers. Studies suggest EPO receptors are expressed throughout the central nervous system, and EPO may cross the blood-brain barrier. Pre-clinical research has explored EPO’s potential neuroprotective effects in models of ischemic injury, traumatic brain injury, and neurodegenerative conditions — with findings suggesting anti-apoptotic, anti-inflammatory, and remyelination-supporting properties in neural tissue models.

❤️ Cardioprotection & Tissue Repair

Research into EPO’s non-hematopoietic properties has uncovered potential cardioprotective effects. Studies in cardiac ischemia models indicate EPO may reduce cardiomyocyte apoptosis, promote angiogenesis, and support myocardial recovery. Tissue-protection mechanisms have also been explored in renal, hepatic, and skeletal muscle models.

🔬 Anemia & Erythropoietic Disorder Research

EPO remains the benchmark compound for studying anemia-of-chronic-disease, chemotherapy-induced anemia, and renal anemia models. Its reliable, dose-dependent erythropoietic response makes it an indispensable tool for hematological research and the development of EPO-receptor agonist analogs.

Why Choose EhBuddy Research-Grade EPO?

• ✅ Verified Purity — Third-party tested for identity, potency, and sterility
• ✅ Precise Dosing — 3,000 IU/vial lyophilized format for accurate reconstitution
• ✅ Fast Canadian Shipping — Dispatched from Canada with discreet packaging
• ✅ Research-Grade Quality — Manufactured under strict quality-control standards

FOR RESEARCH USE ONLY (RUO). This product is intended strictly for in vitro laboratory research and scientific study. It is not approved for human or veterinary use, consumption, or therapeutic application. All purchases are made for legitimate research purposes only. EhBuddy Peptides assumes no liability for misuse.